Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference10 articles.
1. World Health Organization. Coronavirus disease 2019 (COVID-19)—situation report. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 30 May 2020.
2. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19—preliminary report. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2007764.
3. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;2020:105949.
4. Food and Drug Administration. Emergency use authorization for remdesivir. https://www.fda.gov/media/137564/download. Accessed 30 May 2020.
5. National Institute of Health USNLoM. clinicaltrials.gov. https://clinicaltrials.gov/ct2/results?cond=COVID-19. Accessed 31 May 2020.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献